CLX · Clorox reported Q1 FY2027 adjusted EPS of $1.55, beating the $1.07…

Clorox reported Q1 FY2027 adjusted EPS of $1.55, beating the $1.07 consensus by 44.9%, and revenue of $1.91B, above the $1.88B estimate. The strong beat was driven by the GOJO acquisition and lapping the prior-year ERP inventory drawdown, but gross margin declined 130 bps to 40.4% due to higher commodity and logistics costs. The company maintained its full-year adjusted EPS guidance range of $5.70-$6.00 but expects results near the low end, reflecting persistent inflationary headwinds.

• Q1 FY2027 net sales increased 33% YoY to $1.91B, with GOJO contributing ~15 points and organic sales up 18%
• Adjusted EPS of $1.55 beat consensus of $1.07 by 44.9%
• GAAP diluted EPS was $1.39, up 114% from $0.65 in the year-ago quarter
• Gross margin decreased 130 bps to 40.4%, with GOJO inventory step-up contributing ~50 bps of the decline